TScan Therapeutics (TCRX) Interest Coverage Ratio (2022 - 2025)
TScan Therapeutics (TCRX) has disclosed Interest Coverage Ratio for 4 consecutive years, with 33.99 as the latest value for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 27.42% to 33.99 in Q4 2025 year-over-year; TTM through Dec 2025 was 46.75, a 26.66% decrease, with the full-year FY2025 number at 49.05, down 32.9% from a year prior.
- Interest Coverage Ratio was 33.99 for Q4 2025 at TScan Therapeutics, up from 53.39 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 19.13 in Q4 2022 to a low of 53.39 in Q1 2025.
- A 4-year average of 32.31 and a median of 32.71 in 2024 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: crashed 86.81% in 2024, then grew 27.42% in 2025.
- TScan Therapeutics' Interest Coverage Ratio stood at 19.13 in 2022, then plummeted by 31.05% to 25.07 in 2023, then tumbled by 86.81% to 46.83 in 2024, then increased by 27.42% to 33.99 in 2025.
- Per Business Quant, the three most recent readings for TCRX's Interest Coverage Ratio are 33.99 (Q4 2025), 53.39 (Q1 2025), and 46.83 (Q4 2024).